Pathstone Holdings LLC Has $25.17 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pathstone Holdings LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 48,219 shares of the medical equipment provider’s stock after selling 709 shares during the period. Pathstone Holdings LLC’s holdings in Intuitive Surgical were worth $25,169,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $2,401,493,000. Proficio Capital Partners LLC grew its holdings in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Capital Research Global Investors boosted its position in shares of Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $313,769,000. Finally, Northern Trust Corp boosted its position in shares of Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after acquiring an additional 494,496 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. The trade was a 63.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,680 shares of company stock valued at $16,854,345 over the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $565.94 on Thursday. The firm has a market cap of $202.84 billion, a PE ratio of 88.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The firm’s fifty day moving average is $502.26 and its 200-day moving average is $535.79. Intuitive Surgical, Inc. has a 52 week low of $386.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the previous year, the business earned $1.50 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Evercore ISI reduced their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Finally, UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.